Linzagolix
| CAS No. | 935283-04-8 | Cat. No. | BCP30444 |
| Name | Linzagolix | ||
| Synonyms | KLH-2109; OBE-2109; | ||
| Formula | C22H15F3N2O7S | M. Wt | 508.42 |
| Description | Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. | ||
| Pathways | GPCR/G Protein | ||
| Targets | GnRH Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.